Home1541 • HKG
add
ImmuneOnco Biopharmaceuticls Shanghi Inc
Previous close
$6.25
Day range
$6.03 - $6.51
Year range
$3.21 - $22.00
Market cap
2.59B HKD
Avg Volume
3.70M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 39.41M | 1,099.47% |
Operating expense | 119.19M | 17.41% |
Net income | -75.05M | 28.06% |
Net profit margin | -190.43 | 94.00% |
Earnings per share | — | — |
EBITDA | -77.53M | 18.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 752.12M | 23.59% |
Total assets | 922.00M | 5.42% |
Total liabilities | 243.69M | 92.94% |
Total equity | 678.30M | — |
Shares outstanding | 407.31M | — |
Price to book | 3.74 | — |
Return on assets | -21.63% | — |
Return on capital | -24.48% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -75.05M | 28.06% |
Cash from operations | -2.51M | 97.87% |
Cash from investing | -1.16M | 99.10% |
Cash from financing | 118.71M | -22.26% |
Net change in cash | 115.38M | 222.10% |
Free cash flow | -39.46M | 5.33% |
About
Founded
2015
Website
Employees
156